Drug profile · INN
moclobemide
AURORIX 300 MG
moclobemide (AURORIX 300 MG) is a monoamine oxidase a inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — moclobemide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
moclobemide (AURORIX 300 MG) is a monoamine oxidase a inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN moclobemide
Brand AURORIX 300 MG
Mechanism Monoamine oxidase A inhibitor
Target Amine oxidase [flavin-containing] A
Originator Alphapharm Pty Ltd
Mechanism of action
Monoamine oxidase A inhibitor
Primary target: Amine oxidase [flavin-containing] A
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is moclobemide?
moclobemide (AURORIX 300 MG) is a monoamine oxidase a inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for moclobemide?
AURORIX 300 MG is a marketed brand name for moclobemide. Check FDA Drugs@FDA for the current US label holder and prescribing information.